am 251 and colforsin
am 251 has been researched along with colforsin in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dubinett, SM; Gardner, B; Liu, Q; Makriyannis, A; Sharma, S; Tashkin, DP; Zu, LX | 1 |
| New, DC; Wong, YH | 1 |
| Fowler, CJ; Jacobsson, SO; Nilsson, O | 1 |
| Engler, C; Feuerstein, TJ; Steffens, M; Zentner, J | 1 |
| Konishi, S; Rusakov, D; Saitow, F; Satake, S | 1 |
| Armstrong, H; Fong, TM; Hagmann, W; Shen, CP; Xiao, JC | 1 |
| de la Cal, C; Elverdin, JC; Fernández-Solari, J; Iribarne, M; McCann, SM; Prestifilippo, JP; Rettori, V; Suburo, AM | 1 |
| Elverdin, JC; Fernandez-Solari, J; Ossola, CA; Prestifilippo, JP; Rettori, V | 1 |
Other Studies
8 other study(ies) available for am 251 and colforsin
| Article | Year |
|---|---|
Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta.
Topics: 1-Methyl-3-isobutylxanthine; Autocrine Communication; Blotting, Northern; Blotting, Western; Camphanes; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Down-Regulation; Dronabinol; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; GTP-Binding Proteins; Humans; Immunoenzyme Techniques; Lymphocytes; Models, Biological; Paracrine Communication; Piperidines; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; RNA; Transforming Growth Factor beta; Up-Regulation; Virulence Factors, Bordetella | 2002 |
BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.
Topics: Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Humans; Indomethacin; Inositol Phosphates; Ligands; Morpholines; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Second Messenger Systems | 2003 |
Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures.
Topics: Animals; Arachidonic Acids; Cannabinoids; Cells, Cultured; Chick Embryo; Colforsin; Cyclic AMP; Cyclohexanols; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Endocannabinoids; Excitatory Amino Acid Antagonists; Glutamic Acid; L-Lactate Dehydrogenase; Models, Animal; Neurons; Pipecolic Acids; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Telencephalon | 2003 |
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.
Topics: Adenylyl Cyclases; Amygdala; Animals; Arachidonic Acids; Benzoxazines; Binding Sites; Colforsin; Cyclic AMP; Cyclohexanols; Dopamine; Dronabinol; Electric Stimulation; Endocannabinoids; Female; Humans; Ligands; Male; Morpholines; Naphthalenes; Neocortex; Piperidines; Polyunsaturated Alkamides; Potassium; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Synaptosomes; Tetrodotoxin; Tritium | 2004 |
AMPA receptor-mediated presynaptic inhibition at cerebellar GABAergic synapses: a characterization of molecular mechanisms.
Topics: Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiadiazines; Benzoxazines; Calcium; Calcium Channel Blockers; Cerebellum; Chelating Agents; Colforsin; Cyclopropanes; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; In Vitro Techniques; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Piperidines; Presynaptic Terminals; Pyrazoles; Rats; Rats, Wistar; Receptors, AMPA; Ryanodine; Synapses; Triazines; Triazoles | 2004 |
F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
Topics: Alanine; Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Gene Expression; Humans; Indoles; Molecular Structure; Pertussis Toxin; Phenylalanine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Tritium | 2006 |
Inhibition of salivary secretion by activation of cannabinoid receptors.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Colforsin; Cyclic AMP; Endocannabinoids; Immunohistochemistry; Indoles; Male; Methacholine Chloride; Norepinephrine; Parasympathomimetics; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Saliva; Submandibular Gland; Sympathomimetics | 2006 |
Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion.
Topics: Amidohydrolases; Animals; Arachidonic Acid; Arachidonic Acids; Cannabinoid Receptor Modulators; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Endocannabinoids; Etanercept; Immunoglobulin G; Immunologic Factors; In Vitro Techniques; Indoles; Lipopolysaccharides; Male; Methacholine Chloride; Muscarinic Agonists; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Saliva; Salivation; Secretory Rate; Submandibular Gland; Tumor Necrosis Factor-alpha | 2010 |